Bristol-Myers Squibb Co. (BMY) Misses Q4 EPS by 2c, Sales Fall Just Short
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $63.31 -0.46%
EPS Growth %: +5.5%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.5 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- BMS Sotyktu shows sustained efficacy in psoriatic arthritis at two years
- Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
